NEW YORK (GenomeWeb) – Cytox said today that it has raised £2.6 million ($3.3 million) in new financing. The British genetics company will use the proceeds to support the roll out of its Alzheimer's disease testing service.

GM&C Life Sciences Fund — a Manchester, UK-based seed and early stage venture capital fund managed by Catapult Ventures — led the round as a new investor. Existing investors Perivoli Innovations, the Rainbow Seed Fund, the University of Oxford, and other private investors also contributed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.

Researchers report that while host genetics influence the oral microbiome, they don't appear to affect cavity-causing microbes, the Economist says.

Pandas' gut microbiomes change as what they eat changes with the seasons, writes Discover's Inkfish blog.

In PLOS this week: comparative genomic study of malaria-linked macaque parasite, search for apple root reference genes, and more.